From @Breakingviews: GSK in 2018 decided to hive off its unit that makes Advil painkillers and will list a new business called Haleon in London. The point of this break up is to unleash the potential of its remaining pharma business, @aimeedonnellan explains  https://t.co/X5XpzMTn5T